Algert Global LLC Intellia Therapeutics, Inc. Transaction History
Algert Global LLC
- $2.55 Billion
- Q1 2024
A detailed history of Algert Global LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 16,800 shares of NTLA stock, worth $385,560. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,800
Previous 14,700
14.29%
Holding current value
$385,560
Previous $448,000
3.13%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding NTLA
# of Institutions
314Shares Held
89.3MCall Options Held
686KPut Options Held
599K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11MShares$252 Million2.16% of portfolio
-
Black Rock Inc. New York, NY9.11MShares$209 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$209 Million0.01% of portfolio
-
State Street Corp Boston, MA4.6MShares$106 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.21MShares$96.6 Million3.83% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.74B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...